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Abstract
Campylobacter coli is a rare cause of bacteremia. We report here the first case of C.coli spondylodiscitis complicated
by an aortic aneurysm. Outcome was favourable with surgery and antibiotic therapy.
Background
While Campylobacter fetus is a rare but well-recognized
cause of bacteremia [1-3], only a few cases of Campylo-
bacter coli bacteremia have been reported in the litera-
ture. To the best of our knowledge, no aortic aneurysm
due to C.coli has been previously described. We report
here the first case of C.coli spondylodiscitis complicated
by an aortic aneurysm.
Case Presentation
A 72-year old man was admitted in June 2006 in the
Rheumatology Department of the General Hospital of
Valenciennes-France, for a history of lumbar pain evol-
ving for one month. He had a previous medical history
of myocardial injury, dyslipidaemia and tobacco intoxi-
cation; he had neither diabetes mellitus nor immuno-
suppressive therapy. The patient lived in a city and had
only a dog. No chills or rigors, but several episodes of
nocturnal fever, were noted. At admission, the patient
was afebrile, and reported only lumbar back pain and
sciatic pain. White blood cell count was 13,000 G/L,
ESR 89 mm/h and CRP 138.5 mg/L. Blood cultures
taken at admission grew a Gram-negative bacillus. The
strain was identified as C.coli with the API Campy iden-
tification system, and was susceptible to all tested anti-
biotics. Treatment with a combination of cefotaxime
plus gentamicin was immediately started. MRI showed
abnormalities consistent with a L4-L5 spondylodiscitis
associated with prevertebral and left psoas abscesses.
Abdominal CT scan showed a ruptured abdominal aor-
tic aneurysm and a contiguous left psoas collection
(figure 1, 2). The patient was transferred to the Univer-
sity Hospital of Lille to be operated on for insertion of
endovascular prosthesis. He was then transferred to our
Infectious Disease Unit where antibiotic treatment for
the aneurysm and spondylodiscitis was continued.
In our unit, the patient remained afebrile without
pain. Nevertheless, C-reactive protein continued to
markedly rise to 105 mg/L. Ciprofloxacin was added to
cefotaxime, and gentamicin was stopped after two weeks
of treatment. The day after his admission to our unit,
septic shock occurred. CT scan showed the persistence
o fa1 0×7 . 7×3 . 7c mp e r i - a o r t i c a lc o l l e c t i o n ,m a y b e
due to a hematoma related to the first surgical interven-
tion. Surgical drainage was immediately performed (cul-
tures from intraoperative samples were sterile).
Postoperative evolution was favourable except for slight
resolvable renal failure. CT scan carried out two weeks
after surgery showed a marked reduction in the size of
the collection and a decrease in the CRP level to 16 mg/
L at the same time. Transoesophagal echocardiography
was normal. A coloscopy was performed which revealed
only a 5 mm non-resecable caecal polyp. Cefotaxime
was stopped after two weeks and ciprofloxacin was
switched to oral form and is still ongoing. 4 months
after surgery, the CT scan showed the disappearance of
the initial collection. Two years later, the patient con-
tinues to be in good health and remains totally
asymptomatic.
Discussion
Except for one study [4], the incidence of C.coli bactere-
mia remains unknown [5] but seems to be very rare.
This is likely due to the susceptibility of this pathogen
to the antibacterial activity of the serum [6]. This could
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reported in immunocompromised patients or in children
[5,7-12]. Only a few studies report bacteremia occurring
in immunocompetent patients during acute enteritis
[4,13]. Therefore, the incidence of C.coli bacteremia may
be underestimated due to infrequent blood sampling at
the early stage of infection, and inappropriate culture
conditions [14].
Although bacteremia may be misdiagnosed, aortic
aneurysm and spondylodiscitis are more highly visible
infections. Nevertheless, no cases of these localizations
have been reported for C.coli. We found only one case
of meningitis due to this pathogen, but observed no
arthritis, endocarditis, pneumonia or prostatitis. We
have no evidence for an associated endocarditis and
colonoscopy revealed only a small non-inflammatory
polyp. We also did not find any cause of immunosup-
pression in our patient except for age >65 years. Skir-
row et al [4] found the average incidence of
Campylobacter bacteremia to be 1.5/1,000 intestinal
Campylobacter infections in their total population, and
5.9/1000 in patients aged 65 or over.A combination of
c e p h a l o s p o r i na n dg e n t a m i c i nw a sc h o s e ni na n
attempt to obtain a synergistic bactericidal effect dur-
ing the first ten days of treatment. Ciprofloxacin was
prescribed as prolonged antibiotic therapy in an
attempt to obtain permanent high concentrations at
the infected site. Although a 3 months duration of
treatment for abdominal aortic aneurysms infected
with Campylobacter has been evocated in two cases
[15,16], considering that an endovascular prosthesis
h a db e e ni n s e r t e di na ni n f e c t e ds i t ea n dt h er i s ko f
relapsing infection, we considered a life-long antibiotic
suppressive therapy as reported for other bacteria
[17,18]. A prolonged course of ciprofloxacin was then
proposed to the patient due to its activity toward for-
eign body infection due to Gram-negative bacilli, as
demonstrated in both experimental and clinical studies
[19-22].
Concerning the spondylodiscitis, despite some
reported studies [23-25], as drainage of the prevertebral
and left psoas abscesses was done during the first surgi-
cal intervention; no specific intervention was then
performed.
We believe that the spondylodiscitis was primarily due
to C.coli bacteremia, but it is unclear as to whether the
aneurysm rupture was secondary to bacteremia or to
erosion of the arterial wall by the abscess.
A limitation of our case report is that species identifi-
cation was made with the API Campy identification sys-
tem and not by PCR. As previously reported the
sensibility of the API Campy test, particularly for identi-
fication of C.coli, is poor [26-28]. Despite imperfect spe-
cificity of this test, diagnosis of C.coli was always
confirmed by PCR in these studies. In accordance with
these data, the possibility of misdiagnosing Campylobac-
ter species in the present case seems to be very low.
Figure 1 An axial CT image (the first to be performed for this
patient, at the General Hospital, Valenciennes-France) with
contrast of the lumbar area showing abdominal aortic
aneurysm.
Figure 2 A sagittal CT image of the lumbar area with contrast
reconstruction showing abdominal aortic aneurysm.
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Although it had not yet been described, C.coli may be
responsible for spondylodiscitis complicating bacteremia.
Like C.fetus, C.coli may, under conditions not yet eluci-
dated, cross the intestinal barrier and cause severe meta-
static infections.
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